Mealey's (May 17, 2017, 10:43 AM EDT) -- NEW YORK — The New York federal judge overseeing the newly created Eliquis multidistrict litigation on May 9 ordered all plaintiffs to show cause why her May 8 dismissal of one case should not be applied to all cases (In Re: Eliquis [Apixaban] Products Liability Litigation, MDL Docket No. 2754, No. 17-md-2754, Charlie Utts, et al. v. Bristol-Myers Squibb Company, et al., No. 16-5668, S.D. N.Y., 2017 U.S. Dist. LEXIS 73017)....